News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
798,789 Results
Type
Article (80541)
Company Profile (576)
Press Release (717672)
Section
Business (220600)
Career Advice (3774)
Deals (38736)
Drug Delivery (113)
Drug Development (89102)
Employer Resources (185)
FDA (17575)
Job Trends (16760)
News (379293)
Policy (38046)
Tag
Academia (2975)
Alliances (54728)
Alzheimer's disease (1323)
Approvals (17470)
Artificial intelligence (138)
Bankruptcy (379)
Best Places to Work (12414)
Biotechnology (410)
Breast cancer (119)
Cancer (996)
Cardiovascular disease (92)
Career advice (3213)
Cell therapy (233)
Clinical research (69926)
Collaboration (355)
Compensation (174)
COVID-19 (2794)
Data (890)
Diabetes (150)
Diagnostics (6618)
Drug pricing (100)
Earnings (85685)
Employer resources (162)
Events (125153)
Executive appointments (263)
FDA (18043)
Funding (313)
Gene therapy (173)
GLP-1 (672)
Government (5021)
Healthcare (20672)
Infectious disease (2876)
Inflammatory bowel disease (115)
Interviews (720)
IPO (17491)
Job creations (4698)
Job search strategy (2646)
Layoffs (484)
Legal (9463)
Lung cancer (173)
Manufacturing (175)
Medical device (14361)
Medtech (14366)
Mergers & acquisitions (21253)
Metabolic disorders (431)
Neuroscience (1593)
NextGen Class of 2024 (7575)
Non-profit (5059)
Northern California (1254)
Obesity (254)
Opinion (241)
Patents (103)
People (62998)
Pharmaceutical (111)
Phase I (21634)
Phase II (30504)
Phase III (22901)
Pipeline (218)
Postmarket research (3217)
Preclinical (9773)
Radiopharmaceuticals (256)
Rare diseases (205)
Real estate (7064)
Regulatory (24905)
Research institute (2638)
Resumes & cover letters (595)
Southern California (1122)
Startups (4147)
United States (12670)
Vaccines (639)
Weight loss (212)
Date
Today (257)
Last 7 days (913)
Last 30 days (3236)
Last 365 days (38305)
2024 (32767)
2023 (42523)
2022 (53891)
2021 (58695)
2020 (57642)
2019 (51289)
2018 (39050)
2017 (36785)
2016 (37533)
2015 (43564)
2014 (38126)
2013 (34496)
2012 (36524)
2011 (36468)
2010 (36056)
Location
Africa (1171)
Arizona (202)
Asia (47505)
Australia (8307)
California (2919)
Canada (1199)
China (221)
Colorado (128)
Connecticut (139)
Europe (108306)
Florida (411)
Georgia (111)
Illinois (380)
Indiana (193)
Kansas (101)
Maryland (564)
Massachusetts (2463)
Michigan (162)
Minnesota (267)
New Jersey (875)
New York (880)
North Carolina (785)
Northern California (1254)
Ohio (134)
Pennsylvania (766)
South America (1560)
Southern California (1122)
Texas (416)
Washington State (353)
798,789 Results for "de duve institute at the catholique university of louvain".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test
October 8, 2024
·
3 min read
Press Releases
FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
October 23, 2024
·
7 min read
Business
Echosens Appoints Dr. Victor De Lédinghen as Chief Medical Officer
Echosens announced the appointment of Victor de Lédinghen, MD PhD, as the company’s new Chief Medical Officer.
March 26, 2024
·
2 min read
Press Releases
Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
October 1, 2024
·
7 min read
Press Releases
Colossal Achieves Multiple Scientific Firsts in Progress Towards Thylacine De-Extinction
October 17, 2024
·
11 min read
Business
Evergreen Theragnostics announces licensing of EVG321 from Medical University of Innsbruck and enters clinical development of Radioligand Therapies in small cell lung cancer
Evergreen Theragnostics, Inc. today announced that they have entered into a collaboration and licensing-agreement with the Medical University of Innsbruck (MUI), a leading European research institution to advance the development of novel radiopharmaceuticals.
May 21, 2024
·
3 min read
Press Releases
Peytant Solutions, Inc. Granted FDA De Novo for AMStent® Tracheobronchial Covered Stent System
October 22, 2024
·
2 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator.
June 21, 2024
·
4 min read
Press Releases
Healgen’s At-Home COVID-19 and Influenza Test Achieves FDA De Novo Status with Key Support from CovarsaDx® Research Team
October 9, 2024
·
3 min read
1 of 79,879
Next
